States lost $2.3 billion in Medicaid drug rebates in 2024 due to the expanded 340B program, with Pennsylvania, Illinois, and Massachusetts hit hardest.

Adam Colborn, JD, associate vice president of congressional affairs at AMCP, shares insights on the impact of the Most ...

However, Waters has announced plans to merge with BD's life science and diagnostics segment in early 2026, which will dilute that interest in that highly regulated end market, going forward. The ...

U.S. Reps. Raja Krishnamoorthi, D-Ill., and Earl “Buddy” Carter, R-Ga., along with nine other representatives, introduced a bipartisan PBM Reform Act, with regulations centered around Medicare and ...

FDA Commissioner Marty Makary, MD, said the agency may fast-track new drugs from pharmaceutical companies that equalize the cost of their medicines between the U.S. and other countries, Bloomberg ...

Australia's drug approval system is under fire, with critics in the United States claiming it is too slow to approve ...